{
    "clinical_study": {
        "@rank": "153043", 
        "arm_group": {
            "arm_group_label": "vaccinated group", 
            "arm_group_type": "Experimental", 
            "description": "Vaccinated group means that subjects whose antibodies less than 1:40 6 months later after primary vaccination will receive a booster dose of seasonal influenza vaccine."
        }, 
        "brief_summary": {
            "textblock": "This clinical study will be performed in subjects aged 12-60 years old enrolled in\n      NCT01310374 who received 2010 seasonal influenza vaccine to evaluate the persistence of the\n      immune response of influenza vaccine up to 24 months after vaccination."
        }, 
        "brief_title": "Persistence of Immune Response After Vaccination With Influenza Vaccine", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Influenza, Human", 
            "Immunisation Reaction"
        ], 
        "condition_browse": {
            "mesh_term": "Influenza, Human"
        }, 
        "detailed_description": {
            "textblock": "Subjects were previously vaccinated at 12 to 60 years of age with 2010 seasonal influenza\n      vaccine.The persistence phase starts 24 months after the primary vaccination and blood\n      samples will be taken at 6, 12, 18 and 24 months after primary vaccination. Subjects whose\n      antibody titer less than 1:40 at 6 months after primary vaccination will receive a booster\n      dose of influenza vaccine."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  aged 12-60 years old\n\n          -  male or non-pregnant female\n\n          -  volunteers received 2010 seasonal influenza vaccine\n\n          -  clinically healthy as determined by: medical history inquiring and physical\n             examination\n\n          -  provide written informed consents before joining the trial\n\n        Exclusion Criteria:\n\n          -  without history of 2010 seasonal influenza vaccine administration,\n\n          -  allergic to any ingredient of vaccine,\n\n          -  autoimmune disease or immunodeficiency,\n\n          -  severe adverse reaction after vaccination, such as allergies, hives, breathing\n             difficulties, angioedema or abdominal pain,\n\n          -  severe acute and chronic diseases\n\n          -  axillary temperature over 37.0\u2103 at the time of vaccination."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": {
            "#text": "207", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01906190", 
            "org_study_id": "BJCDCWJ201104"
        }, 
        "intervention": {
            "arm_group_label": "vaccinated group", 
            "description": "subjects whose antibodies less than 1:40 6 months later after primary vaccination will receive a booster dose of seasonal influenza vaccine", 
            "intervention_name": "seasonal influenza vaccine", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "influenza vaccine", 
            "immune response", 
            "persistence"
        ], 
        "lastchanged_date": "July 19, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tuoketuo County", 
                    "country": "China", 
                    "state": "Inner Mongolia", 
                    "zip": "102000"
                }, 
                "name": "Tuoketuo Centers for Disease Control & Prevention"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "Persistence Study of Immune Response After Vaccination With Influenza Vaccine in Healthy Population", 
        "overall_official": {
            "affiliation": "Beijing Centers for Disease Control and Prevention", 
            "last_name": "jiang wu, Bachelor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Persistence of antibodies in all subjects with respect to components of the investigational vaccine - month 6\uff0c12\uff0c18\uff0c24", 
            "measure": "change from serum antibodies against vaccine-related influenza virus at 6,12,18,24 months", 
            "safety_issue": "No", 
            "time_frame": "6\uff0c12\uff0c18\uff0c24 months after the primary vaccination"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01906190"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centers for Disease Control and Prevention, China", 
            "investigator_full_name": "Wu Jiang", 
            "investigator_title": "Department of Immunization & Prevention, Beijing Centers for Disease Control and Prevention", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Centers for Disease Control and Prevention, China", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centers for Disease Control and Prevention, China", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2011", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}